Humoral response after BNT162b2 vaccine in Japanese of hemodialysis patients
Not Applicable
- Conditions
- Hemodialysis patients
- Registration Number
- JPRN-UMIN000046999
- Lead Sponsor
- Fujita Memorial Hospital
- Brief Summary
The anti-SARS-CoV-2 IgG antibody positivity rate after BNT162b2 vaccine administration was 181/185 = 97.8% in the hemodialysis patients.The median antibody titer in hemodialysis patients was 2728.7 AU/mL, with a quartile range of 1024.2-7688.2 AU/mL.Adverse events associated with vaccine administration were mild.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 185
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with no history of COVID-19
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acquisition rate of SARS-CoV-2 IgG antibody after BNT162b2 vaccination
- Secondary Outcome Measures
Name Time Method Adverse events of BNT162b2 vaccine